Lu Tianyu, Yu Chen, Ni Hongbin, Liang Weibang, Yan Huiying, Jin Wei
Department of Neurosurgery, Nanjing Drum Tower Hospital Clinical College of Nanjing Medical University, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.
Department of Neurosurgery, The Affiliated Drum Tower Hospital of Nanjing University Medical School, 321 Zhongshan Road, Nanjing, 210008, Jiangsu, China.
Int J Dev Neurosci. 2018 Jun;67:46-50. doi: 10.1016/j.ijdevneu.2018.03.009. Epub 2018 Mar 28.
Aggressive growth hormone-secreting pituitary adenomas (GHPAs) represent an important clinical problem in patients with acromegaly. Surgical therapy, although often the mainstay of treatment for GHPAs, is less effective in aggressive GHPAs due to their invasive and destructive growth patterns, and their proclivity for infrasellar invasion. LncRNAs are important players in cancer development and emerging in various fundamental biological processes. In the present study, qRT-PCR was performed to examine the expression of lncRNA H19 and MALAT-1 in invasive and non-invasive GHPAs. Our results revealed that the expression of lncRNA H19 was remarkably higher in invasive GHPAs, however, there was no significant differences between the expression of lncRNA MALAT-1 in invasive GHPAs and non-invasive GHPAs, suggesting that lncRNA H19 may play an important role in GHPA invasion. LncRNA H19 might be a target for the study of GHPAs invasion, and a potential index for the diagnosis or prognosis of GHPAs.
侵袭性生长激素分泌型垂体腺瘤(GHPAs)是肢端肥大症患者的一个重要临床问题。手术治疗虽然通常是GHPAs的主要治疗方法,但由于侵袭性GHPAs具有侵袭性和破坏性的生长模式以及向鞍下侵袭的倾向,手术治疗效果较差。长链非编码RNA(lncRNAs)是癌症发展中的重要参与者,并在各种基本生物学过程中出现。在本研究中,采用qRT-PCR检测lncRNA H19和MALAT-1在侵袭性和非侵袭性GHPAs中的表达。我们的结果显示,lncRNA H19在侵袭性GHPAs中的表达显著更高,然而,lncRNA MALAT-1在侵袭性GHPAs和非侵袭性GHPAs中的表达没有显著差异,这表明lncRNA H19可能在GHPA侵袭中起重要作用。lncRNA H19可能是研究GHPAs侵袭的一个靶点,也是GHPAs诊断或预后的一个潜在指标。